Biophore India Pharma, Akum Drugs and Pharma and 1 other ink pact for research of range of products for multiple therapies

Published On 2022-12-01 08:45 GMT   |   Update On 2022-12-01 08:45 GMT
Advertisement

New Delhi: Akums Drugs & Pharmaceuticals has announced that it has partnered with Leiutis Pharmaceuticals LLP and Biophore India Pharmaceuticals for the research and development of a range of products for multiple therapies. 

The companies will look at products to cater to various segments like CNS (Central Nervous System) disorders, pain management, and hormonal disorders.

The focus of the companies in this partnership is to synergise capabilities, leverage research, and bring innovative products in specific therapeutic areas, within the next five years, both in India and other global markets and with the first few products expected to be commercialised in the next two years, the drug contract development and manufacturing organisation said in a statement.

Advertisement

''A significantly large number of patients suffer from diseases in India and globally, requiring treatment for several years and often having suboptimal experience with the available treatment options.

''In association with Leiutis and Biophore, we are committing to bringing unique products made available to the physicians and patients for improved clinical outcomes,'' Akums Founder and Promoter Sanjeev Jain said.

This tripartite association will see Akums manufacture and commercialise the products created by Leiutis and Biophore.

Read also: Akums Drugs and Pharma expects to touch Rs 10,000 crore turnover in next five years

Akums Drugs & Pharmaceuticals Ltd, Haridwar, (India) is a contract manufacturing pharmaceutical company in India. The organization manufactures and exports formulations in a wide spectrum of dosage forms & therapeutic segments. The 10 state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (Injectable, eye, ear & nasal), hormonal (oral and injectable), Ointments & cosmetics, Ayurvedic, food supplements & nutraceuticals and animal health care. 
The organization is certified with WHO-GMP, ISO 9001 : 2008, ISO 14001:2004 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi amongst others.

Read also: Akum Pharma gets CDSCO panel nod to manufacture, market antihypertensive FDC drug

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News